Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions.

NCT00883155 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT00883155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions.
Lead sponsor
Sandoz
Phase
Phase 1
Overall status
Completed
Start date
October 31, 1998
Completion date
October 31, 1998
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy